K4 Elite logo K4 Elite
Home / Peptide Library / DSIP (Delta Sleep-Inducing Peptide)
Limited Research

DSIP (Delta Sleep-Inducing Peptide)

Cognitive & Neurological · ['Delta sleep-inducing peptide', 'DSIP', 'WAGGDASGE']

DSIP is a naturally occurring nonapeptide first isolated from mammalian brain, studied in research contexts related to sleep-associated electrophysiology and neuroendocrine and stress-response measures.

🔬 Research use only — not for human or veterinary use. K4 Elite does not provide dosing instructions.
Molecular Formula
C35H48N10O15
Molecular Weight
848.8 g/mol
PubChem
CID 68816 ↗
Research Level
Limited Research
Available in our store →
DSIP (Delta Sleep-Inducing Peptide) chemical structure

Delta sleep-inducing peptide (DSIP) is a naturally occurring nonapeptide with the sequence WAGGDASGE, originally isolated from the cerebral venous blood of rabbits in sleep research [1]. Its name derives from early observations associating it with delta-wave (slow-wave) electroencephalographic activity in animal studies.

DSIP has been examined in a range of research contexts including sleep-associated electrophysiology, neuroendocrine measures, and stress-response and thermoregulatory endpoints, though the published literature remains limited and findings are heterogeneous [1][2].

It is described in the scientific literature as an endogenous peptide of research interest; it is not an established therapeutic agent at the time of writing.

The precise mechanism of DSIP remains incompletely characterized in the literature. Studies have reported associations with neuroendocrine regulation, modulation of certain neurotransmitter and hormone systems, and effects on sleep-related electrophysiological measures in animal models, but a single defined receptor mechanism has not been firmly established [1][2].

All described associations are drawn from cited studies and characterize research findings rather than outcomes for any individual.

  • Sleep-associated electrophysiology (delta/slow-wave activity) in animal models [1]
  • Neuroendocrine and hormonal parameters, including stress-axis measures [2]
  • Thermoregulatory and circadian-related endpoints in preclinical studies [1]
  • Antioxidant and stress-response biochemistry in experimental models [2]
  • Peptide stability and blood-brain-barrier transport characterization [1]
📋 How published studies were conducted — a research reference summarizing study designs from the literature. This is not usage, dosing, or administration guidance. K4 Elite does not provide dosing instructions; determining any research protocol is the sole responsibility of the qualified researcher.

Preclinical sleep electrophysiology studies: Early animal research administered DSIP and recorded electroencephalographic measures, reporting associations with delta-wave activity that informed the peptide's naming; subsequent studies reported heterogeneous results [1]. Reported here for scientific reference only.

Neuroendocrine / stress-response studies: Experimental studies in rodent models examined DSIP's association with stress-axis hormones and oxidative-stress biomarkers, reporting the measured biochemical endpoints [2].

Combinations examined in the research literature. Descriptive only — not a recommendation to combine compounds.

GABAergic / sleep-related agentsNeutral
Sleep-electrophysiology endpoints are co-studied; mechanism not firmly established [1].
Corticotropin / stress-axis hormonesCompatible
Neuroendocrine measures studied together in DSIP research [2].
Melatonin / circadian modulatorsNeutral
Circadian and sleep endpoints overlap in the research literature.
Antioxidant compoundsCompatible
Oxidative-stress biomarkers examined in experimental DSIP studies [2].
  1. Schoenenberger GA, Monnier M. Characterization of a delta-EEG-sleep-inducing peptide. PNAS. 1977
  2. PubChem CID 68816 — Delta sleep-inducing peptide
  3. DSIP neuroendocrine & stress research (PubMed)
What is DSIP?
A naturally occurring nonapeptide (WAGGDASGE) first isolated from mammalian brain in sleep research [1].
Is DSIP's mechanism understood?
No. The literature describes associations with sleep electrophysiology and neuroendocrine measures, but a single defined receptor mechanism is not firmly established [1][2].
What research areas involve DSIP?
Published studies span sleep-associated electrophysiology, neuroendocrine/stress-axis measures, thermoregulation, and oxidative-stress biochemistry [1][2].
Is DSIP an approved therapeutic?
No. It is described in the literature as an endogenous peptide of research interest, not an established therapeutic agent [1].
Is this product for personal use?
No. It is supplied for laboratory research use only and is not intended for human or veterinary use, nor to diagnose, treat, cure, or prevent any disease.
Disclaimer: This profile summarizes published preclinical and laboratory research for reference only. It is not medical advice and makes no claim of safety or efficacy in humans. Determining any research protocol is the sole responsibility of the qualified researcher. Products are sold strictly for in-vitro research and have not been evaluated by the FDA.